Aurinia Pharmaceuticals Inc call shares owned by Group One Trading
Quarter-by-quarter ownership of Aurinia Pharmaceuticals Inc call shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Aurinia Pharmaceuticals Inc call
Tip: Access up to 7 years of quarterly data
All positions including Aurinia Pharmaceuticals Inc call held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aurinia Pharmaceuticals Inc call by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.8M | 341k | 11.05 |
| 2025-06-30 | $2.5M | 301k | 8.47 |
| 2025-03-31 | $3.7M | 461k | 8.04 |
| 2024-12-31 | $3.3M | 372k | 8.98 |
| 2024-09-30 | $3.8M | 523k | 7.33 |
| 2024-06-30 | $3.1M | 538k | 5.71 |
| 2024-03-31 | $2.3M | 466k | 5.01 |
| 2023-09-30 | $5.1M | 654k | 7.77 |
| 2023-06-30 | $8.9M | 923k | 9.68 |
| 2023-03-31 | $8.0M | 729k | 10.96 |
| 2022-12-31 | $2.8M | 653k | 4.32 |
| 2022-09-30 | $4.6M | 618k | 7.52 |
| 2022-06-30 | $3.8M | 378k | 10.05 |
| 2022-03-31 | $7.5M | 610k | 12.38 |
| 2021-12-31 | $27M | 1.2M | 22.87 |
| 2021-09-30 | $14M | 634k | 22.13 |
| 2021-06-30 | $2.7M | 210k | 12.96 |
| 2021-03-31 | $2.4M | 187k | 12.99 |
| 2020-12-31 | $5.1M | 368k | 13.83 |
| 2020-09-30 | $3.3M | 223k | 14.73 |
| 2020-06-30 | $3.0M | 185k | 16.25 |
| 2020-03-31 | $4.4M | 307k | 14.51 |
| 2019-12-31 | $8.4M | 416k | 20.26 |
| 2019-09-30 | $670k | 125k | 5.34 |
| 2019-06-30 | $273k | 42k | 6.58 |
| 2019-03-31 | $312k | 48k | 6.50 |
| 2018-12-31 | $59k | 8.7k | 6.78 |
| 2018-09-30 | $661k | 100k | 6.64 |
| 2018-06-30 | $574k | 102k | 5.63 |
| 2018-03-31 | $227k | 44k | 5.19 |
| 2017-12-31 | $546k | 121k | 4.53 |
| 2017-09-30 | $44k | 7.0k | 6.29 |
| 2017-06-30 | $288k | 47k | 6.13 |
| 2017-03-31 | $2.0M | 271k | 7.34 |
| 2016-12-31 | $210k | 100k | 2.10 |
Top funds holding Aurinia Pharmaceuticals Inc call
View all funds holding Aurinia Pharmaceuticals Inc call